Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid
โ Scribed by Zornitsa I. Zlatarova; Ekaterina B. Softova; Klara G. Dokova; Elisabeth M. Messmer
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 607 KB
- Volume
- 250
- Category
- Article
- ISSN
- 0065-6100
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these
## Background: The 5-year survival rate of patients with submucosal (sm) esophageal carcinoma continues to be much worse than that with intramucosal (m) lesions. the reasons are unclear, but matrix metalloproteinases (mmps) and membrane type matrix metalloproteinases (mt-mmps) are known to be invol
Degradation of the extracellular matrix (ECM) is an essential step in tumour invasion and metastasis. The matrix metalloproteinases (MMPs) each have different substrate specificities within the ECM and are important in its degradation. MMP activity is dependent on the levels of activated MMP and tis